Inventor · disambiguated record
Patricia Mcneeley
Also filed as: MCNEELEY PATRICIA · MCNEELEY PATRICIA A
4 granted patents·7 pending applications·32 citations·filing 2000–2024
76Inventor score
Top patents by PatentIndex Score
11 records- 0195US11440954B2Optimized anti-TL1A antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2020·Granted Sep 13, 2022·7 cites·20 claims
- 0295US11292848B2Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2020·Granted Apr 5, 2022·14 cites·20 claims
- 0392US11999789B2Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2022·Granted Jun 4, 2024·2 cites·7 claims
- 0485US2024368263A1Optimized anti-tl1a antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0578US2023192835A1Optimized anti-tl1a antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0678US2024327532A1Humanized antibodies to tnf-like ligand 1a (tl1a) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0773US7081242B1Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereofJOLLA PHARMA·Filed 2000·Granted Jul 25, 2006·9 cites·64 claims
- 0867US2021070871A1Optimized anti-tl1a antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 0962US2023272098A1Methods, systems, and kits for treatment of inflammatory diseases targeting tl1aPROMETHEUS BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1046US2011039258A1Methods and compositions for differential expansion of fetal cells in maternal blood and their useCELULA INC·Filed 2007·Application pending·0 cites
- 1145US2006142229A1Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereofJOLLA PHARMA·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patricia Mcneeley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →